An exhaustive gene expression profiling study on a widely used mouse model of AD that expressed mouse APP with three AD-associated mutations (Swedish mutations in exon 16, and Beyreuther/Iberian and Arctic mutations in exon 17) (Saito et al., 2014), showing the heterogeneity in both homeostatic and reactive microglia. This evidence concerns the gene APP and Alzheimer disease.